Glenmark Pharmaceuticals informs about media release

21 Dec 2020 Evaluate

Glenmark Pharmaceuticals has informed that it has attached media release on 21st December 2020 titled ‘Glenmark Pharmaceuticals receives ANDA tentative approval for Dabigatran Etexilate Capsules, 75 mg, 110 mg, and 150 mg’ which is self explanatory.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

2012.00 19.30 (0.97%)
29-Jan-2026 14:22 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1593.65
Dr. Reddys Lab 1205.40
Cipla 1321.00
Zydus Lifesciences 887.75
Lupin 2128.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×